Risedronate Sodium
Brand names: Risedronate Sodium Dr, Actonel, Atelvia, Risedronate Sodium
At a glance
- Medicare prescriptions, 2024
- 139,512
- Medicare drug cost
- $11.6M
- Average cost per prescription
- $83.47
- Clinicians who prescribed it
- 5,876
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Risedronate sodium tablets are a bisphosphonate indicated for: Treatment and prevention of postmenopausal osteoporosis Treatment to increase bone mass in men with osteoporosis Treatment and prevention of glucocorticoid-induced osteoporosis Treatment of Paget’s disease Limitations of Use Optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use.
From the FDA-approved prescribing information (label dated March 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Internal Medicine 26.5%
- Family Medicine 21.2%
- Endocrinology & Diabetes 16.7%
- Rheumatology 12.0%
- Nurse Practitioners 8.4%
- OB-GYN (Obstetrics & Gynecology) 4.9%
- Physician Assistants 3.6%
- General Practice 2.7%
- Geriatric Medicine 0.9%
- Orthopedic Surgery 0.3%
- Hematology & Oncology 0.3%
- Sports Medicine 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 1% from 2019 to 2024.
Biggest change by state since 2019
- North Carolina +31%
- Michigan +21%
- Florida +12%
- Connecticut +11%
- Puerto Rico +10%
- Texas (smallest change) −16%
- Arizona (smallest change) −14%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 3 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Allergan, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 30.1 mg / 4.9 mg risedronate sodium monohydrate | yellow oval tablet, 12 mm | EC 35 |
Mylan Pharmaceuticals, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 30.1 mg / 4.9 mg risedronate sodium monohydrate | yellow oval tablet, 12 mm | EC 35 |
Teva Pharmaceuticals USA, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 5 mg | yellow round tablet, 9 mm | TEVA 7390 |
| 30 mg | white round tablet, 9 mm | TEVA 7391 |
| 35 mg | orange round tablet, 9 mm | TEVA 7389 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Mar 2022 · Macleods Pharma Usa Inc · Class III
FAILED CONTENT UNIFORMITY SPECIFICATIONS
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.